Bri-Chem Corp. saw a modest increase this week amidst minimal company news.
Bri-Chem Corp. (BRY.TO) experienced a slight uptick in its stock price this week, gaining 3.57% over the past seven days. Despite this positive movement, the company has faced challenges recently, including declining sales figures in its financial reports. Let's take a closer look at the current situation surrounding Bri-Chem's stock and its recent performance.
Advertisement
Bri-Chem Corp.
BRY.TO
BRY.TO
Bri-Chem Corp.
WealthAwesomeMarket cap
$7.67M
P/E
7.3x
52W high
$0.44
52W low
$0.20
1W change
+3.57%
Beta
-0.75
Analyst Price Targets
Based on analyst covering BRY
Wall Street analysts forecast BRY stock price to fall 24.1% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.22
-24.1% Upside
Current Price
C$0.29
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRY's historical volatility
30-Day Vol
84.3%
Annualized
90-Day Vol
73.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.24
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.27 | C$0.20 โ C$0.37 |
| 60 trading days | C$0.26 | C$0.17 โ C$0.39 |
| 90 trading days | C$0.24 | C$0.15 โ C$0.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Bri-Chem's stock remains under pressure with declining sales and mixed analyst sentiment. Investors should keep an eye on the company's financial health and upcoming strategic decisions.
Bri-Chem Corp. has a market cap of approximately C$7.67 million.
With a P/E ratio of 7.25, Bri-Chem's valuation may seem attractive; however, its low profit margin of 1.3% raises concerns about profitability and operational effectiveness.
Bull case
The recent renewal of Bri-Chem's senior banking facility provides financial stability, which may support future operational flexibility and growth initiatives. This move could help the company navigate its current challenges and position itself for potential recovery.
Bear case
Declining sales in recent quarters and bearish analyst outlooks could hinder the company's recovery and impact investor confidence. If these trends continue, they may create further obstacles for Bri-Chem as it seeks to improve its financial standing.
Recent Price Action
Advertisement
Bri-Chem Corp. closed at C$0.29, reflecting no change in price for the day. Over the past week, the stock has risen by 3.57%, although it has seen a more significant decline of 21.62% over the past month. Year-to-date, the stock is up 31.82%, indicating some recovery from earlier lows.
Company News and Catalysts
While there have been no major announcements from Bri-Chem Corp. this week, recent headlines highlight several important developments. The company held its Annual General Meeting on June 19, 2026, where all nominated directors were elected, and Kingston Ross Pasnak LLP was appointed as independent auditors. Additionally, on May 5, 2026, Bri-Chem renewed its senior banking facility with CIBC, securing a $25 million borrowing base until April 30, 2027. These actions are crucial for maintaining operational stability amid declining sales.
Technical Picture
From a technical standpoint, Bri-Chem's stock is currently trading below its 50-day moving average of C$0.33, representing an 11.6% discount. The 200-day moving average stands at C$0.30, only slightly above the current price, indicating a bearish trend. The stock has a 52-week range of C$0.20 to C$0.44, with the current price at 37% of this range. The stock's beta is -0.75, suggesting lower volatility compared to the broader market. Notably, trading volume has surged, with the latest volume at 42,019 shares, nearly double the 20-day average of 21,715 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
